DUBLIN, Ireland--(BUSINESS WIRE)--Research and Markets (http://www.researchandmarkets.com/reports/c85214) has announced the addition of “US Pharmaceutical Industry - PEST Framework Analysis” to their offering.
Pharmaceutical is one of the most intense “Knowledge Driven” industries, which is continually in a state of dynamic transition. Diversities in life forms and diseases pose stiff challenge to the design of specific and targeted solutions. The process of “drug discovery/invention” is elaborate requiring on an average 8-10 years at a cost of US$ 300 million to reach a new drug to the market.
The US continues to generate the highest growth in the global pharmaceutical industry, and analysts continue to witness robust sales results in the country. An increasingly robust drug development pipeline, ageing populations, and the ongoing demand for innovative therapies are the driving forces behind this growth of the US Pharmaceutical Industry.
A PEST analysis is concerned with the environmental influences on a business. The acronym stands for the Political, Economic, Social and Technological issues that could affect the strategic development of a business. Identifying PEST influences is a useful way of summarizing the external environment in which a business operates.
A. Executive Summary
B. Introduction to the Industry
B.1 Industry Definition
B.2 Industry Profile
B.3 Industry Structure
B.4 Future Outlook
C. PEST Framework Analysis
C.1 Political Aspects
C.2 Economic Aspects
C.3 Social Aspects
C.4 Technological Aspects
D. Glossary of Terms
For more information visit http://www.researchandmarkets.com/reports/c85214.